{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:42:21Z","timestamp":1759538541735,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01CA210961"],"award-info":[{"award-number":["P01CA210961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Quantum Leap Healthcare Collaborative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Neoadjuvant chemotherapy (NAC) may allow de-escalation of axillary surgery; yet treatment disparities persist. We aimed to assess race-based disparities in use of axillary lymph node surgery (ALND) among patients who achieve a nodal response in the context of a large, multicenter NAC trial.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective analysis of the I-SPY 2 trial. All patients received NAC, but type of surgery was not mandated. Multivariable logistic regression was used to predict odds ratio (OR) of undergoing ALND by race while adjusting for clinical and demographic confounders, including age, region, tumor receptor subtype, clinical and pathologic node status (cN and ypN +\/\u2212, respectively), and clinical and pathologic tumor size (cT and ypT, respectively).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 1394 patients, 79.4% identified as White, 11.2% Black, and 9.4% Asian\/other. More than half (52.5%) were cN+ at baseline, and 66.9% were ypN- after NAC, with no significant differences in nodal downstaging by race. Overall ALND rates were higher in Black patients (50.6%) compared to White (37.5%) and Asian\/other (38.9%) patients (<jats:italic>p\u2009<\/jats:italic>=\u20090.007). Notably, among those who converted from cN+ to ypN\u2212, Black patients underwent ALND more frequently (62%) than White (41.2%) and Asian\/other (40%) patients (<jats:italic>p\u2009<\/jats:italic>=\u20090.021). In multivariable analysis, Black patients had 70% higher odds of undergoing ALND compared with White patients (OR 1.7, 95% confidence interval (CI) 1.09\u20132.66, <jats:italic>p\u2009<\/jats:italic>=\u20090.02).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite no differences in nodal downstaging, Black patients in I-SPY 2 were significantly more likely to undergo ALND. These disparities may stem from unmeasured patient, provider, or systemic factors affecting surgical planning.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17864-y","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T13:51:18Z","timestamp":1753278678000},"page":"8211-8219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial"],"prefix":"10.1245","volume":"32","author":[{"given":"Mandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Dimitroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Yau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Tchou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Quirarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa M.","family":"Howard-McNatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla","family":"Switalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Kuerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"Sauder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Postlewait","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cletus","family":"Arciero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roshni","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Reyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Gutnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Taunk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"DeMichele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas","family":"Yee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nola M.","family":"Hylton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Fraser","family":"Symmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Shatsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Isaacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Rudra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Pohlmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Alvarado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Jaskowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Prionas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehra","family":"Golshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara A.","family":"Piltin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olufunmilayo I.","family":"Olopade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita A.","family":"Mukhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"6","key":"17864_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrclinonc.2015.63","volume":"12","author":"TA King","year":"2015","unstructured":"King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12(6):335\u201343. https:\/\/doi.org\/10.1038\/nrclinonc.2015.63.","journal-title":"Nat Rev Clin Oncol"},{"key":"17864_CR2","doi-asserted-by":"publisher","unstructured":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO.1997.15.7.2483","DOI":"10.1200\/JCO.1997.15.7.2483"},{"issue":"14","key":"17864_CR3","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455\u201361. https:\/\/doi.org\/10.1001\/jama.2013.278932.","journal-title":"JAMA"},{"issue":"3","key":"17864_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/BF02573060","volume":"9","author":"V Stearns","year":"2002","unstructured":"Stearns V, Ewing CA, Slack R, Penannen MF, Hayes DF, Tsangaris TN. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol. 2002;9(3):235\u201342. https:\/\/doi.org\/10.1007\/BF02573060.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"17864_CR5","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1245\/s10434-023-13759-y","volume":"30","author":"JC Boughey","year":"2023","unstructured":"Boughey JC, Yu H, Dugan CL, et al. Changes in surgical management of the axilla over 11 years: report on more than 1500 breast cancer patients treated with neoadjuvant chemotherapy on the prospective I-SPY2 Trial. Ann Surg Oncol. 2023;30(11):6401\u201310. https:\/\/doi.org\/10.1245\/s10434-023-13759-y.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"17864_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ijrobp.2013.02.018","volume":"86","author":"M Kim","year":"2013","unstructured":"Kim M, Kim SW, Lee SU, et al. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy. Int J Radiat Oncol Biol Phys. 2013;86(3):498\u2013503. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.02.018.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"17864_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.breast.2016.04.011","volume":"28","author":"SL Kilbreath","year":"2016","unstructured":"Kilbreath SL, Refshauge KM, Beith JM, et al. Risk factors for lymphoedema in women with breast cancer: a large prospective cohort. Breast Edinb Scotl. 2016;28:29\u201336. https:\/\/doi.org\/10.1016\/j.breast.2016.04.011.","journal-title":"Breast Edinb Scotl"},{"issue":"20","key":"17864_CR8","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMcp1803290","volume":"379","author":"SG Rockson","year":"2018","unstructured":"Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937\u201344. https:\/\/doi.org\/10.1056\/NEJMcp1803290.","journal-title":"N Engl J Med"},{"issue":"2","key":"17864_CR9","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s13193-011-0078-2","volume":"2","author":"P Brar","year":"2011","unstructured":"Brar P, Jain S, Singh I. Complications of axillary lymph node dissection in treatment of early breast cancer: a comparison of MRM and BCS. Indian J Surg Oncol. 2011;2(2):126\u201332. https:\/\/doi.org\/10.1007\/s13193-011-0078-2.","journal-title":"Indian J Surg Oncol"},{"issue":"7","key":"17864_CR10","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/(sici)1097-0142(19981001)83:7<1362::aid-cncr13>3.0.co;2-2","volume":"83","author":"MA Warmuth","year":"1998","unstructured":"Warmuth MA, Bowen G, Prosnitz LR, et al. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer. 1998;83(7):1362\u20138. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19981001)83:7%3c1362::aid-cncr13%3e3.0.co;2-2.","journal-title":"Cancer"},{"issue":"8","key":"17864_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamasurg.2014.23","volume":"149","author":"DM Black","year":"2014","unstructured":"Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg. 2014;149(8):788. https:\/\/doi.org\/10.1001\/jamasurg.2014.23.","journal-title":"JAMA Surg"},{"key":"17864_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jss.2020.03.063","volume":"254","author":"A Nayyar","year":"2020","unstructured":"Nayyar A, Strassle PD, Schlottmann F, et al. Disparities in the use of sentinel lymph node dissection for early stage breast cancer. J Surg Res. 2020;254:31\u201340. https:\/\/doi.org\/10.1016\/j.jss.2020.03.063.","journal-title":"J Surg Res"},{"issue":"1","key":"17864_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjsurg.2007.09.035","volume":"196","author":"RJ Kenney","year":"2008","unstructured":"Kenney RJ, Marszalek JM, McNally ME, Nelson BV, Herati AS, Talboy GE. The effects of race and age on axillary lymph node involvement in breast cancer patients at a Midwestern safety-net hospital. Am J Surg. 2008;196(1):64\u20139. https:\/\/doi.org\/10.1016\/j.amjsurg.2007.09.035.","journal-title":"Am J Surg"},{"issue":"12","key":"17864_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.49646","volume":"6","author":"B Kyalwazi","year":"2023","unstructured":"Kyalwazi B, Yau C, Campbell MJ, et al. Race, gene expression signatures, and clinical outcomes of patients with high-risk early breast cancer. JAMA Netw Open. 2023;6(12):e2349646. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.49646.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"17864_CR15","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.1245\/s10434-021-09657-w","volume":"28","author":"T Relation","year":"2021","unstructured":"Relation T, Obeng-Gyasi S, Bhattacharyya O, et al. Racial differences in response to neoadjuvant chemotherapy: impact on breast and axillary surgical management. Ann Surg Oncol. 2021;28(11):6489\u201397. https:\/\/doi.org\/10.1245\/s10434-021-09657-w.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"17864_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","volume":"26","author":"P Rastogi","year":"2008","unstructured":"Rastogi P, Anderson SJ, Bear HD, et al. Preoperative chemotherapy: updates of national surgical adjuvant breast and bowel project protocols B-18 and B-27. J Clin Oncol. 2008;26(5):778\u201385. https:\/\/doi.org\/10.1200\/JCO.2007.15.0235.","journal-title":"J Clin Oncol"},{"issue":"10","key":"17864_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA"},{"issue":"36","key":"17864_CR18","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1200\/JCO.2015.63.7801","volume":"33","author":"BK Killelea","year":"2015","unstructured":"Killelea BK, Yang VQ, Wang SY, et al. Racial differences in the use and outcome of neoadjuvant chemotherapy for breast cancer: results from the national cancer data base. J Clin Oncol. 2015;33(36):4267\u201376. https:\/\/doi.org\/10.1200\/JCO.2015.63.7801.","journal-title":"J Clin Oncol"},{"issue":"14","key":"17864_CR19","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/JCO.23.01199","volume":"42","author":"HE Woriax","year":"2024","unstructured":"Woriax HE, Thomas SM, Plichta JK, et al. Racial\/ethnic disparities in pathologic complete response and overall survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2024;42(14):1635\u201345. https:\/\/doi.org\/10.1200\/JCO.23.01199.","journal-title":"J Clin Oncol"},{"issue":"3","key":"17864_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.3329","volume":"6","author":"F Zhao","year":"2023","unstructured":"Zhao F, Miyashita M, Hattori M, et al. Racial disparities in pathological complete response among patients receiving neoadjuvant chemotherapy for early-stage breast cancer. JAMA Netw Open. 2023;6(3):e233329. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.3329.","journal-title":"JAMA Netw Open"},{"issue":"17","key":"17864_CR21","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1002\/cncr.25296","volume":"116","author":"M Chavez-MacGregor","year":"2010","unstructured":"Chavez-MacGregor M, Litton J, Chen H, et al. Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy. Cancer. 2010;116(17):4168\u201377. https:\/\/doi.org\/10.1002\/cncr.25296.","journal-title":"Cancer"},{"issue":"3","key":"17864_CR22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s10549-015-3350-2","volume":"150","author":"JR Tichy","year":"2015","unstructured":"Tichy JR, Deal AM, Anders CK, Reeder-Hayes K, Carey LA. Race, response to chemotherapy, and outcome within clinical breast cancer subtypes. Breast Cancer Res Treat. 2015;150(3):667\u201374. https:\/\/doi.org\/10.1007\/s10549-015-3350-2.","journal-title":"Breast Cancer Res Treat"},{"issue":"18","key":"17864_CR23","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1002\/cncr.32296","volume":"125","author":"SM Walsh","year":"2019","unstructured":"Walsh SM, Zabor EC, Stempel M, Morrow M, Gemignani ML. Does race predict survival for women with invasive breast cancer? Cancer. 2019;125(18):3139\u201346. https:\/\/doi.org\/10.1002\/cncr.32296.","journal-title":"Cancer"},{"issue":"7","key":"17864_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jamaoncol.2021.1254","volume":"7","author":"B Cho","year":"2021","unstructured":"Cho B, Han Y, Lian M, et al. Evaluation of racial\/ethnic differences in treatment and mortality among women with triple-negative breast cancer. JAMA Oncol. 2021;7(7):1016\u201323. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1254.","journal-title":"JAMA Oncol"},{"issue":"5","key":"17864_CR25","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.canep.2015.07.010","volume":"39","author":"TF Akinyemiju","year":"2015","unstructured":"Akinyemiju TF, Vin-Raviv N, Chavez-Yenter D, Zhao X, Budhwani H. Race\/ethnicity and socio-economic differences in breast cancer surgery outcomes. Cancer Epidemiol. 2015;39(5):745\u201351. https:\/\/doi.org\/10.1016\/j.canep.2015.07.010.","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"17864_CR26","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1001\/jamasurg.2017.0005","volume":"152","author":"LA Newman","year":"2017","unstructured":"Newman LA, Kaljee LM. Health disparities and triple-negative breast cancer in African American women: a review. JAMA Surg. 2017;152(5):485\u201393. https:\/\/doi.org\/10.1001\/jamasurg.2017.0005.","journal-title":"JAMA Surg"},{"issue":"4","key":"17864_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaoncol.2022.7705","volume":"9","author":"KF Hoskins","year":"2023","unstructured":"Hoskins KF, Calip GS, Huang HC, Ibraheem A, Danciu OC, Rauscher GH. Association of social determinants and tumor biology with racial disparity in survival from early-stage, hormone-dependent breast cancer. JAMA Oncol. 2023;9(4):536\u201345. https:\/\/doi.org\/10.1001\/jamaoncol.2022.7705.","journal-title":"JAMA Oncol"},{"issue":"4","key":"17864_CR28","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.3390\/ijerph20042903","volume":"20","author":"LA Lovejoy","year":"2023","unstructured":"Lovejoy LA, Shriver CD, Haricharan S, Ellsworth RE. Survival disparities in US black compared to white women with hormone receptor Positive-HER2 negative breast cancer. Int J Environ Res Public Health. 2023;20(4):2903. https:\/\/doi.org\/10.3390\/ijerph20042903.","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"17864_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s10549-011-1398-1","volume":"128","author":"KE Reeder-Hayes","year":"2011","unstructured":"Reeder-Hayes KE, Bainbridge J, Meyer AM, et al. Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat. 2011;128(3):863\u201371. https:\/\/doi.org\/10.1007\/s10549-011-1398-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"17864_CR30","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/archsurg.2011.196","volume":"146","author":"W Olaya","year":"2011","unstructured":"Olaya W, Morgan JW, Lum SS. Unnecessary axillary surgery for patients with node-negative breast cancer undergoing total mastectomy. Arch Surg. 2011;146(9):1029\u201333. https:\/\/doi.org\/10.1001\/archsurg.2011.196.","journal-title":"Arch Surg"},{"issue":"2","key":"17864_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1524-4741.2002.08203.x","volume":"8","author":"CE Cox","year":"2002","unstructured":"Cox CE, Dupont E, Whitehead GF, et al. Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002;8(2):88\u201391. https:\/\/doi.org\/10.1046\/j.1524-4741.2002.08203.x.","journal-title":"Breast J"},{"issue":"1","key":"17864_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amjsurg.2003.04.004","volume":"187","author":"M Hughes","year":"2004","unstructured":"Hughes M, Goffman TG, Perry RR, Laronga C. Obesity and lymphatic mapping with sentinel lymph node biopsy in breast cancer. Am J Surg. 2004;187(1):52\u20137. https:\/\/doi.org\/10.1016\/j.amjsurg.2003.04.004.","journal-title":"Am J Surg"},{"issue":"6","key":"17864_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jamcollsurg.2003.08.005","volume":"197","author":"AM Derossis","year":"2003","unstructured":"Derossis AM, Fey JV, Cody HSI, Borgen PI. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer. J Am Coll Surg. 2003;197(6):896. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2003.08.005.","journal-title":"J Am Coll Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17864-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17864-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T16:06:58Z","timestamp":1759507618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17864-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17864"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17864-y","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}